Unelected “public health” bureaucrats and others will be meeting on January 26 to review data presented to them by vaccine manufacturers, and will use that limited information to decide whether there should be adjustments to the current authorizations, approvals, and schedules for COVID-19 primary and booster jabs. Do you trust this process? If not, you aren’t alone and, fortunately, this committee is accepting public comments! Read below for all the important information and simple instructions on how to submit your concerns and questions.
What you need to know:
The FDA Vaccines and Related Biological Products Advisory Committee is meeting on Jan 26, 2023 “to consider whether and how the composition for primary doses of the currently available COVID-19 vaccines should be modified and how and whether the composition and schedule for booster doses should be adjusted moving forward. Along with the independent experts of the advisory committee, representatives from the U.S. Centers for Disease Control and Prevention and the National Institutes of Health will also participate in the meeting.”
Who is this committee?
The committee is mostly made up of medical doctors in the fields of infectious disease and pediatrics, along with bureaucrats and academics. Prolific vaccine shill Dr. Paul Offitt, who recently surprised vaccine skeptics by veering from the accepted narrative when he recommended against bivalent boosters for infants, children and adolescents.
What is this committee’s job?
The committee is tasked with reviewing “data concerning the safety, effectiveness, and appropriate use of vaccines” and assess the “quality and relevance of FDA’s research program”. At the January 26 meeting, the committee will “meet in open session to discuss the future vaccination regimens addressing COVID-19”, including whether and how the primary dose and booster schedule should be adjusted.
The committee will review submitted data about vaccine safety and efficacy of the monovalent and bivalent COVID-19 vaccines currently in use, and whether to recommend changes to the current authorizations and approvals.
It is important to note that, as recently as the June 2022 meeting of this committee, government officials and vaccine manufacturers knowingly withheld data that would have cast doubt on the reliability of these vaccines.
What can you do?
Provide public comment and attend online! Details below:
Submit Public Comment:
Federal eRulemaking Portal: https://www.regulations.gov re: Docket No. FDA-2022-N-2810 for “Vaccines and Related Biological Products Advisory Committee (VRBPAC)
Ideas/concerns to discuss in your public comment:
- What fail safes have been put in place since the June meeting to ensure the committee is presented with complete and transparent data?
- What consequences or adjustment will result if it is later found that manufacturers and government researchers did not provide full and accurate information?
- In light of studies which find that waning immunity and unpredictable variant revolution are responsible for continued transmission, what steps are being taken to ensure evidence-based recommendations are made?
- The goal posts are continually being adjusted as we learn more about the ineffectiveness of these vaccines and boosters at achieving their original aims (ie, preventing transmission). We now see that most deaths are in vaccinated people and the boosters are estimated to only be 50% effective at lowering hospitalization rates. When will the committee settle on what is expected of its vaccine program?